Cannabinoids, hippocampal excitability and efficacy for the treatment of epilepsy

Pharmacol Ther. 2019 Oct:202:32-39. doi: 10.1016/j.pharmthera.2019.06.002. Epub 2019 Jun 7.

Abstract

Interest in cannabis and its related cannabinoids THC and CBD for use as anti-convulsant therapy has been progressively increasing. While the destigmatization of cannabis and cannabis related research have progressed in the last few decades, there are still many questions that remain unanswered. This review seeks to summarize the progress made in cannabis research in the past four decades and to identify possible directions for future research that are critical for the development of cannabinoid-based therapy in epilepsy.

Keywords: (9)THC; Cannabidiol; Cannabis; Epilepsy; Hippocampus; Therapy.

Publication types

  • Review

MeSH terms

  • Animals
  • Cannabidiol / pharmacology
  • Cannabidiol / therapeutic use
  • Cannabinoids / pharmacology*
  • Cannabinoids / therapeutic use*
  • Cannabis / chemistry
  • Dronabinol / pharmacology
  • Dronabinol / therapeutic use
  • Epilepsy / drug therapy*
  • Hippocampus / drug effects*
  • Humans

Substances

  • Cannabinoids
  • Cannabidiol
  • Dronabinol